Screening for inflammation in this context can involve measuring biomarkers such as high-sensitivity C-reactive protein (hs-CRP), IL-6, and TNF-α, which are indicative of systemic inflammation and may serve as early indicators of CKD risk in individuals with elevated TyG index values [34]. The gene discussed is IL6; the disease is chronic kidney disease.